Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

Laufs, Ulrich; Birkenfeld, Andreas L.; Fraass, Uwe; Hohenstein, Bernd; Siegert, Carsten; Klotsche, Jens; Steinhagen-Thiessen, Elisabeth; Pittrow, David; Dexl, Stefan; Salmen, Sunnhild; Schettler, Volker J. J.; Parhofer, Klaus G.

dc.contributor.author	Birkenfeld, Andreas L.
dc.date.accessioned	2025-04-08T06:59:13Z
dc.date.available	2025-04-08T06:59:13Z
dc.date.issued	2024
dc.identifier.issn	0920-3206
dc.identifier.uri	http://hdl.handle.net/10900/163883
dc.language.iso	en	de_DE
dc.publisher	Dordrecht : Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s10557-022-07386-0	de_DE
dc.subject.ddc	610	de_DE
dc.title	Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240422000000_01546
utue.publikation.seiten	119-129	de_DE
utue.personen.roh	Laufs, Ulrich
utue.personen.roh	Birkenfeld, Andreas L.
utue.personen.roh	Fraass, Uwe
utue.personen.roh	Hohenstein, Bernd
utue.personen.roh	Siegert, Carsten
utue.personen.roh	Klotsche, Jens
utue.personen.roh	Steinhagen-Thiessen, Elisabeth
utue.personen.roh	Pittrow, David
utue.personen.roh	Dexl, Stefan
utue.personen.roh	Salmen, Sunnhild
utue.personen.roh	Schettler, Volker J. J.
utue.personen.roh	Parhofer, Klaus G.
dcterms.isPartOf.ZSTitelID	Cardiovascular Drugs and Therapy	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	38	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE